# Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol

> **NCT07166783** · PHASE1 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Health Subjects

## Interventions

- **DRUG:** Tolvaptan

## Key facts

- **NCT ID:** NCT07166783
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-16
- **Primary completion:** 2011-07-04
- **Final completion:** 2011-07-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07166783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07166783, "Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07166783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*